In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies
Since the first approval of monoclonal antibodies by the United States Food and Drug Administration (FDA) in 1986, therapeutic antibodies have become one of the predominant classes of drugs in oncology and immunology. Despite their natural function in contributing to antiviral immunity, antibodies a...
Saved in:
Main Authors: | Silvere Pagant (Author), Rachel A. Liberatore (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancing In Vivo Electroporation Efficiency through Hyaluronidase: Insights into Plasmid Distribution and Optimization Strategies
by: Debnath Maji, et al.
Published: (2024) -
Plasmid DNA Delivery into the Skin via Electroporation with a Depot-Type Electrode
by: Yuya Yoshida, et al.
Published: (2024) -
Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice
by: Marie-Lynn Cuypers, et al.
Published: (2023) -
Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana
by: Kelsi Swope, et al.
Published: (2022) -
Rapid, inexpensive, fingerstick, whole-blood, sensitive, specific, point-of-care test for anti-Toxoplasma antibodies.
by: Joseph Lykins, et al.
Published: (2018)